dihydroergotamine has been researched along with Abnormalities, Drug-Induced in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, D; Bérard, A; Kori, S; Strom, S; Zhao, JP | 1 |
| Hohmann, M; Künzel, W | 1 |
2 other study(ies) available for dihydroergotamine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Dihydroergotamine; Female; Follow-Up Studies; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Migraine Disorders; Pregnancy; Premature Birth; Prospective Studies; Quebec; Tryptamines; Young Adult | 2021 |
Dihydroergotamine causes fetal growth retardation in guinea pigs.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Dihydroergotamine; Female; Fetal Growth Retardation; Guinea Pigs; Litter Size; Maternal-Fetal Exchange; Placenta; Pregnancy; Regional Blood Flow; Vascular Resistance | 1992 |